April 25, 2017 4:51 AM ET

Pharmaceuticals

Company Overview of Shionogi Pharma, Inc.

Company Overview

Shionogi Pharma, Inc. produces, markets, and sells branded prescription products focused on cardiovascular, diabetes, women's health, and pediatric treatment. It offers oral suspensions, tablets, and capsules, as well as products prescribed by the primary care physicians. The company provides cardiovascular and diabetes products that treat patients with high cholesterol, hypertension, high triglycerides, unstable angina, and Type 2 diabetes; pediatrics products, which treat allergies, asthma, cough and cold, and attention deficit and hyperactivity disorders; and products for the health and well-being of women, as well as for mothers and their babies. It develops glycopyrrolate oral solution,...

Five Concourse Parkway

Suite 1800

Atlanta, GA 30328

United States

Founded in 1992

950 Employees

Phone:

770-442-9707

Fax:

770-442-9594

Key Executives for Shionogi Pharma, Inc.

Vice President of Regulatory Affairs & Quality Assurance
Compensation as of Fiscal Year 2016.

Shionogi Pharma, Inc. Key Developments

Horizon Announces Proposes Private Offering of Senior Notes

Horizon Pharma plc announced that Horizon Pharma, Inc. and Horizon Pharma USA, Inc., its wholly owned subsidiaries, intend, subject to market and other considerations, to offer $300 million aggregate principal amount of senior notes due 2024, and to borrow $375 million aggregate principal amount of incremental term loans under Horizon’s existing senior secured credit facility. Horizon currently expects to use the net proceeds from the offering of notes and the incremental term loans to fund a portion of Horizon’s planned acquisition of Raptor Pharmaceutical Corp., repay Raptor’s outstanding debt, and pay any prepayment premiums, fees and expenses in connection with the foregoing. The notes and the incremental term loans will be fully and unconditionally guaranteed by Horizon, as well as by certain of its existing and future subsidiaries. The notes will be offered only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended and to non-U.S. buyers in accordance with Regulation S under the Securities Act. The notes have not been and are not expected to be registered under the Securities Act or under any state securities laws and, unless so registered, may not be offered or sold in the United States or to U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

Shionogi Pharma, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-05-2016

Shionogi Pharma, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-05-2016. Venue: The Ritz-Carlton, Laguna Niguel, California, United States. Presentation Date & Speakers: Oct-05-2016, Joe Whalen, Senior Vice President, Business Development & Alliance Management.

Shionogi Pharma, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 02:00 PM

Shionogi Pharma, Inc. Presents at Jefferies 2016 Healthcare Conference, Jun-09-2016 02:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Shionogi Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.